Clinical Features and Natural History of Nonalcoholic Steatosis Syndromes

 

 Buy Article Permissions and Reprints

ABSTRACT

Nonalcoholic steatohepatitis, along with other forms of nonalcoholic fatty liver disease, is a chronic liver disease that is attracting increasing significance. It is a clinicopathologic syndrome that was originally described in obese, diabetic females who denied alcohol use but in whom the hepatic histology was consistent with alcoholic hepatitis. This typical patient profile has been expanded and is now recognized to occur even in normal weight males without overt abnormalities in carbohydrate metabolism. Although originally believed to be a benign clinical entity, nonalcoholic steatohepatitis is now recognized as a cause of progressive fibrotic liver disease with adverse clinical sequelae. It is important to emphasize that nonalcoholic steatohepatitis is best considered one type of a larger spectrum of nonalcoholic fatty liver disease that is a consequence of insulin resistance and ranges from fat alone to fat plus inflammation, fat plus ballooning degeneration, and nonalcoholic steatohepatitis, the latter being the most serious form. As with any disease, the clinical importance of nonalcoholic steatohepatitis is related to its prevalence and natural history. Recent studies using different methodologies indicate that in the general population the prevalence of fatty liver and nonalcoholic steatohepatitis is approximately 20% and 3%, respectively. These prevalence rates are increased in certain subpopulations such as obesity and type II diabetes. Of greater concern is the recognition that cirrhosis and liver-related deaths occur in approximately 20% and 8% of these patients, respectively, over a 10-year period. Risk factors for these adverse clinical symptoms include patients older than the age of 45, the presence of diabetes or obesity, an aspartate aminotransferase/alanine aminotransferase ratio >1 and hepatic histology. However, a number of important unresolved issues must be clarified before the true natural history of this disease can be fully understood.

REFERENCES

• 1 Ludwig J, Viggiano T R, McGill D B. Non-alcoholic steatohepatitis. Mayo Clinic experiences with a hither to unnamed disease.  Mayo Clin Proc . 1980;  55 434-438
  PubMedGoogle Scholar
• 2 Adler M, Schaffner F. Fatty liver hepatitis and cirrhosis in obese patients.  Am J Med . 1979;  67 811-816
  CrossrefPubMedGoogle Scholar
• 3 Thaler H. Relation of steatosis to cirrhosis.  Clin Gastroenterol . 1957;  4 273-280
  PubMedGoogle Scholar
• 4 Lee R G. Non-alcoholic steatohepatitis: a study of 49 patients.  Hum Pathol . 1989;  20 594-598
  CrossrefPubMedGoogle Scholar
• 5 Powell E E, Cooksley W G, Hanson R. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years.  Hepatology . 1990;  11 74-80
  CrossrefPubMedGoogle Scholar
• 6 Bacon B R, Farahvash M J, Janney C G. Nonalcoholic steatohepatitis: an expanded clinical entity.  Gastroenterology . 1994;  107 1103-1109
  PubMedGoogle Scholar
• 7 Matteoni C A, Younossi Z M, Gramlich T. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.  Gastroenterology . 1999;  116 1413-1419
  CrossrefPubMedGoogle Scholar
• 8 Fong D G, Nehra V, Lindor K. Metabolic and nutritional considerations in nonalcoholic fatty liver.  Hepatology . 2000;  32 3-10
  CrossrefPubMedGoogle Scholar
• 9 Burt A D, Mutton A, Day C P. Diagnosis and interpretation of steatosis and steatohepatitis.  Semin Diagn Pathol . 1998;  15 246-258
  PubMedGoogle Scholar
• 10 Marchesini G, Brizi M, Morselli-Labate A M. Association of nonalcoholic fatty liver disease with insulin resistance.  Am J Med . 1999;  107 450-455
  Google Scholar
• 11 Itoh S, Igarashi M, Tsukada Y. Nonalcoholic fatty liver with alcoholic hyalin after long term glucocorticoid therapy.  Acta Hepatogastroenterol . 1977;  24 415-418
  PubMedGoogle Scholar
• 12 Seki K, Minami Y, Nishikawa M. ``Nonalcoholic steatohepatitis'' induced by massive doses of synthetic estrogen.  Gastroenterol Jpn . 1983;  18 197-203
  PubMedGoogle Scholar
• 13 Poucell S, Ireton J, Valencia-Mayoral P. Amiodarone-associated phospholipidosis and fibrosis of the liver. Light, immunohistochemical, and electron microscopic studies.  Gastroenterology . 1984;  86 926-936
  PubMedGoogle Scholar
• 14 Pessayre D, Bichara M, Degott C. Perhexiline maleate-induced cirrhosis.  Gastroenterology . 1979;  76 170-177
  PubMedGoogle Scholar
• 15 Barbany G, Uzzan F, Larrey D. Alcoholic-like liver lesions induced by nifedipine.  J Hepatol . 1989;  9 252-255
  PubMedGoogle Scholar
• 16 Hamilton D L, Vest T K, Brown B S. Liver injury with alcoholic like hyalin after gastroplasty for morbid obesity.  Gastroenterology . 1983;  85 722-726
  PubMedGoogle Scholar
• 17 Peters R L. Hepatic morphologic changes after jejunoileal bypass.  Prog Liver Dis . 1979;  6 581-594
  PubMedGoogle Scholar
• 18 Craig R M, Neumann T, Jeejeebhoy K N. Severe hepatocellular reaction resembling alcoholic hepatitis with cirrhosis after massive small bowel resection and prolonged total parenteral nutrition.  Gastroenterology . 1980;  70 131-137
  PubMedGoogle Scholar
• 19 Grimm I S, Schindler W, Haluszka O. Steatohepatitis and fatal hepatic failure after biliopancreatic diversion.  Am J Gastroenterol . 1992;  87 775-779
  PubMedGoogle Scholar
• 20 Partin J S, Partin J C, Schubert W K. Liver ultrastructure in abetalipoproteinemia: evolution of micronodular cirrhosis.  Gastroenterology . 1974;  67 107-118
  PubMedGoogle Scholar
• 21 Tarugi P, Lonardo A, Ballarini G. Fatty liver in heterozygous hypobetalipoproteinemia caused by a novel truncated form of apolipoprotein B.  Gastroenterology . 1996;  111 1125-1133
  CrossrefPubMedGoogle Scholar
• 22 Kimura H, Kako M, Yo K. Alcoholic hyalins (Mallory bodies) in a case of Weber-Christian disease: electron microscopic observations of liver involvement.  Gastroenterology . 1980;  78 807-812
  PubMedGoogle Scholar
• 23 Fleming C R. Hepatobiliary complications in adults receiving nutrition support.  Dig Dis . 1994;  12 191-198
  PubMedGoogle Scholar
• 24 Solis-Herruzo J A, Castellano G, Colina F. Hepatic injury in the toxic epidemic syndrome caused by ingestion of adulterated cooking oil.  Hepatology . 1984;  4 131-139
  PubMedGoogle Scholar
• 25 Nazim M, Stamp G, Hodgson H J. Non-alcoholic steatohepatitis associated with small intestinal diverticulosis and bacterial overgrowth.  Hepatogastroenterology . 1989;  36 349-351
  PubMedGoogle Scholar
• 26 Hautekeete M L, Degott C, Benhamou J P. Microvesicular steatosis of the liver.  Acta Clin Belg . 1990;  45 311-326
  PubMedGoogle Scholar
• 27 Fromenty B, Pessayre D. Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines.  J Hepatol . 1997;  26(suppl 2) 43-53
  PubMedGoogle Scholar
• 28 Fromenty B, Berson A, Pessayre D. Microvesicular steatosis and steatohepatitis: role of mitochondrial dysfunction and lipid peroxidation.  J Hepatol . 1997;  26(suppl 2) 13-22
  PubMedGoogle Scholar
• 29 Nomura H, Kashiwagi S, Hayashi J. Prevalence of fatty liver in a general population of Okinawa, Japan.  Jpn J Med . 1988;  27 142-149
  CrossrefPubMedGoogle Scholar
• 30 Nonomura A, Mizukami Y, Unoura M. Clinicopathologic study of alcohol-like liver disease in non-alcoholics; non-alcoholic steatohepatitis and fibrosis.  Gastroenterol Jpn . 1992;  27 521-528
  PubMedGoogle Scholar
• 31 Araujo L M, DeOliveira D A, Nunes D S. Liver and biliary ultrasonography in diabetic and non-diabetic obese women.  Diabetes Metab . 1998;  24 458-462
  PubMedGoogle Scholar
• 32 Hultcrantz R, Glaumann H, Lindberg G. Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases.  Scand J Gastroenterol . 1986;  21 109-113
  PubMedGoogle Scholar
• 33 Lonardo A, Bellini M, Tartoni P. The bright liver syndrome: prevalence and determinants of a ``bright'' liver echo pattern.  Ital J Gastroenterol Hepatol . 1997;  29 351-356
  PubMedGoogle Scholar
• 34 El-Hassan A Y, Ibrahim E M, Al-Mulhim F A. Fatty infiltration of the liver: analysis of prevalence, radiological and clinical features and influence on patient management.  Br J Radiol . 1992;  65 774-778
  PubMedGoogle Scholar
• 35 Propst A, Propst T, Judmaier G. Prognosis in non-alcoholic steatohepatitis (Letter).  Gastroenterology . 1995;  108 1607
  PubMedGoogle Scholar
• 36 Hilden M, Christoffersen P, Juhl E. Liver histology in a ``normal'' population-examinations of 503 consecutive fatal traffic casualties.  Scand J Gastroenterol . 1977;  12 593-597
  PubMedGoogle Scholar
• 37 Ground K E. Liver pathology in aircrew.  Aviat Space Environ Med . 1982;  53 14-18
  PubMedGoogle Scholar
• 38 Ballentani S, Saccoccio G, Masutti F. Prevalence of and risk factors for hepatic steatosis in northern Italy.  Ann Intern Med . 2000;  132 112-117
  PubMedGoogle Scholar
• 39 Diehl A M, Goodman Z, Ishak K G. Alcohol-like liver disease in non-alcoholics. A clinical and histologic comparison with alcohol-induced liver injury.  Gastroenterology . 1988;  95 1056-1062
  PubMedGoogle Scholar
• 40 Itoh S, Yougel T, Kawagoe K. Comparison between non-alcoholic steatohepatitis and alcoholic hepatitis.  Am J Gastroenterol . 1987;  82 650-654
  PubMedGoogle Scholar
• 41 Angulo P, Keach J C, Batts K P. Independent predictors of liver fibrosis in patients with non-alcoholic steatohepatitis.  Hepatology . 1999;  30 1356-1362
  CrossrefPubMedGoogle Scholar
• 42 Baldridge A D, Perez-Atayde A R, Graeme-Cook F. Idiopathic steatohepatitis in childhood: a multicenter retrospective study.  J Pediatr . 1995;  127 700-704
  PubMedGoogle Scholar
• 43 Moran J R, Ghishan F K, Halter S A. Steatohepatitis in obese children: a cause of chronic liver dysfunction.  Am J Gastroenterol . 1983;  78 374-377
  PubMedGoogle Scholar
• 44 Kinugasa A, Tsunamota K, Furukawa N. Fatty liver and its fibrous changes found in simple obesity of children.  J Pediatr Gastroenterol Nutr . 1984;  3 408-414
  PubMedGoogle Scholar
• 45 Rashid M, Roberts E A. Nonalcoholic steatohepatitis in children.  J Pediatr Gastroenterol Nutr . 2000;  30 48-52
  CrossrefPubMedGoogle Scholar
• 46 Sheth S G, Gordon F D, Chopra S. Non-alcoholic steatohepatitis.  Ann Intern Med . 1997;  126 137-145
  PubMedGoogle Scholar
• 47 Sanyal A J. Non-alcoholic steatohepatitis.  Clin Perspect Gastroenterol . 2000;  (May/June) 129-139
  PubMedGoogle Scholar
• 48 Kumar K S, Malet P F. Nonalcoholic steatohepatitis.  Mayo Clin Proc . 2000;  75 733-739
  PubMedGoogle Scholar
• 49 VanNess M M, Diehl A M. Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes?.  Ann Intern Med . 1989;  111 473-478
  PubMedGoogle Scholar
• 50 Pinto H C, Baptista A, Camilo M E. Non-alcoholic steatohepatitis: clinicopathological comparison with alcohol hepatitis in ambulatory and hospitalized patients.  Dig Dis Sci . 1996;  41 172-179
  PubMedGoogle Scholar
• 51 Fletcher L M, Kwoh-Gain I, Powell L W. Markers of chronic alcohol ingestion in patients with non-alcoholic steatohepatitis: an aid to diagnosis.  Hepatology . 1991;  13 445-459
  CrossrefPubMedGoogle Scholar
• 52 George D K, Goldwurm S, MacDonald G A. Increased hepatic iron concentration in non-alcoholic steatohepatitis is associated with increased fibrosis.  Gastroenterology . 1998;  114 311-318
  CrossrefPubMedGoogle Scholar
• 53 Bonkovsky H L, Jawaid Q, Tortorelli K. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis.  J Hepatol . 1999;  31 421-429
  CrossrefPubMedGoogle Scholar
• 54 Saleh J, Sniderman A D, Cianflone K. Regulation of plasma fatty acid metabolism.  Clin Chem Acta . 1999;  286 163-180
  CrossrefPubMedGoogle Scholar
• 55 Neuschwander-Tetri B A, Bacon B R. Non-alcoholic steatohepatitis.  Med Clin North Am . 1996;  80 1147-1166
  PubMedGoogle Scholar
• 56 Scheuer P J, Ashrafzadeh P, Sherlock S. The pathology of hepatitis C.  Hepatology . 1992;  15 567-571
  PubMedGoogle Scholar
• 57 Moriya K, Yotsuyanagi H, Shintani Y. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice.  J Gen Virol . 1997;  78 1527-1531
  PubMedGoogle Scholar
• 58 Moriya K, Fujie H, Shintani Y. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice.  Nat Med . 1998;  4 1065-1067
  CrossrefPubMedGoogle Scholar
• 59 Rogers D W, Lee C H, Pound D C. Hepatitis C does not cause non-alcoholic steatohepatitis.  Dig Dis Sci . 1992;  37 1644-1647
  PubMedGoogle Scholar
• 60 McCullough A J, Falck-Ytter Y. Body composition and hepatic steatosis as precursors for fibrotic liver disease.  Hepatology . 1999;  29 1328-1330
  CrossrefPubMedGoogle Scholar
• 61 Fiore G, Fera G, Napoli N. Liver steatosis and chronic hepatitis C. A spurious association?.  Eur J Gastroenterol Hepatol . 1996;  8 125-129
  PubMedGoogle Scholar
• 62 McCullough A J, O'Connor J BF. Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology.  Am J Gastroenterol . 1998;  93 2022-2036
  CrossrefPubMedGoogle Scholar
• 63 McCulloough A J. Alcoholic liver disease. In: Schiff ER, Sorrell MF, Maddrey WC (eds). Schiff's Diseases of the Liver, 8th ed. Philadelphia: Lippincott-Raven 1999: 942-971
  Google Scholar
• 64 Teli M R, James O F, Burt A D. The natural history of nonalcoholic fatty liver: a follow-up study.  Hepatology . 1995;  22 1714-1719
  CrossrefPubMedGoogle Scholar
• 65 Coates R A, Halliday M L, Rankin J G. Risk of fatty liver infiltration of cirrhosis of the liver in relation to ethanol consumption: a case-control study.  Clin Invest Med . 1986;  9 26-32
  PubMedGoogle Scholar
• 66 Bird G L, Williams R. Factors determining cirrhosis in alcoholic liver disease.  Mol Aspects Med . 1988;  10 97-105
  PubMedGoogle Scholar
• 67 Becker U, Deis A, Sorensen T I. Prediction of risk of liver disease by alcohol intake, sex and age: a prospective population study.  Hepatology . 1996;  23 1025-1029
  CrossrefPubMedGoogle Scholar
• 68 Naveau S, Giraud V, Borotto E. Excess weight as a risk factor for alcoholic liver disease.  Hepatology . 1997;  25 108-111
  CrossrefPubMedGoogle Scholar
• 69 Bellentani S, Saccoccio G, Costa G. Drinking habits as co-factors of risk for alcohol induced liver damage. The Dionysos Study Group.  Gut . 1997;  41 845-850
  CrossrefPubMedGoogle Scholar
• 70 Kitchens J M. Does this patient have an alcohol problem?.  JAMA . 1994;  272 1782-1787
  CrossrefPubMedGoogle Scholar
• 71 Lumeng L. New diagnostic markers of alcohol abuse.  Hepatology . 1986;  6 742-745
  PubMedGoogle Scholar
• 72 Chick J, Erickson C. Conference summary: Consensus Conference on alcohol dependence and the role of pharmacotherapy in its treatment.  Alcohol Clin Exp Res . 1996;  20 391-402
  PubMedGoogle Scholar
• 73 Storey E L, Anderson G J, Mark U. Desialylated transferrin as a serological marker of chronic excessive alcohol ingestion.  Lancet . 1987;  1 1292-1294
  PubMedGoogle Scholar
• 74 Stibler H. Carbohydrate deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed.  Clin Chem . 1998;  37 2029-2037
  PubMedGoogle Scholar
• 75 Rosman A S, Lieber C S. Diagnostic utility of laboratory tests in alcoholic liver disease.  Clin Chem . 1994;  40 1641-1651
  PubMedGoogle Scholar
• 76 Washington K, Wright K, Shyr Y. Hepatic stellate cell activation in nonalcoholic steatohepatitis and fatty liver.  Hum Pathol . 2000;  31 822-828
  CrossrefPubMedGoogle Scholar
• 77 Brolin R E, Bradley L J, Taliwal R V. Unsuspected cirrhosis discovered during obesity operations.  Arch Surg . 1998;  133 84-88
  CrossrefPubMedGoogle Scholar
• 78 Abdelmalek M, Ludwig J, Lindor K D. Two cases from the spectrum of non-alcoholic steatohepatitis.  J Clin Gastroenterol . 1995;  20 127-130
  PubMedGoogle Scholar
• 79 Caldwell S H, Oelsner D H, Iezzoni J C. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease.  Hepatology . 1999;  29 664-669
  CrossrefPubMedGoogle Scholar
• 80 Wanless I R, Lentz J S. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.  Hepatology . 1990;  12 1106-1110
  CrossrefPubMedGoogle Scholar
• 81 Brunt E M, Janney C G, DiBisceglie A M. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.  Am J Gastroenterol . 1999;  94 2467-2474
  CrossrefPubMedGoogle Scholar
• 82 Younossi Z M, Gramlich T, Liu Y C. Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations.  Mod Pathol . 1998;  11 560-565
  PubMedGoogle Scholar
• 83 U.S. Bureau of the Census Statistical Abstract of the United States. 1997, 117th ed. Washington, DC U.S. Bureau of the Census 1997
• 84 Younossi Z M, Gramlich T, Bacon B R. Hepatic iron and nonalcoholic fatty liver disease.  Hepatology . 1999;  30 847-850
  CrossrefPubMedGoogle Scholar
• 85 Ratziu V, Giral P, Charlotte F. Liver fibrosis in overweight patients.  Gastroenterology . 2000;  118 1117-1123
  CrossrefPubMedGoogle Scholar
• 86 Day C P, James O F. Steatohepatitis: a tale of two ``hits''?.  Gastroenterology . 1998;  114 842-845
  CrossrefPubMedGoogle Scholar
• 87 Sorbi D, Boynton J, Lindor K D. The ratio of aspartate amino transferase to alanine amino transferase: potential value in differentiating non-alcoholic steatohepatitis from alcoholic liver disease.  Am J Gastroenterol . 1999;  94 1018-1022
  PubMedGoogle Scholar
• 88 Andersen T, Gluud C. Liver morphology in morbid obesity: a literature study.  Int J Obes . 1984;  8 97-106
  PubMedGoogle Scholar
• 89 Nasrallah S M, Wills C E, Galambos J T. Hepatic morphology in obesity.  Dig Dis Sci . 1981;  26 325-327
  CrossrefPubMedGoogle Scholar
• 90 Kern W H, Heger A H, Payne J H. Fatty metamorphosis of the liver in morbid obesity.  Arch Pathol . 1973;  96 342-346
  PubMedGoogle Scholar
• 91 Klain J, Fraser D, Goldstein J. Liver histology abnormalities in the morbidly obese.  Hepatology . 1989;  10 873-876
  PubMedGoogle Scholar
• 92 Wanless I R, Bargman J M, Oreopoulos D G. Subcapsular steatonecrosis in response to peritoneal insulin delivery: a clue to the pathogenesis of steatonecrosis in obesity.  Mod Pathol . 1989;  2 69-74
  PubMedGoogle Scholar
• 93 Braillon A, Capron J P, Herve M A. Liver in obesity.  Gut . 1985;  26 133-139
  PubMedGoogle Scholar
• 94 Nomura F, Ohnishi K, Satomura Y. Liver function in moderate obesity-study in 534 moderately obese subjects among 4613 male company employees.  Int J Obes . 1986;  10 349-354
  PubMedGoogle Scholar
• 95 Day C P, James O F. Hepatic steatosis: innocent bystander or guilty party?.  Hepatology . 1998;  27 1463-1466
  CrossrefPubMedGoogle Scholar
• 96 Parola M, Pinzani M, Casini A. Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen α1 (I) gene expression in human liver fat-storing cells.  Biochem Biophys Res Commun . 1993;  194 1044-1050
  CrossrefPubMedGoogle Scholar
• 97 Lee K S, Buck M, Houglum K. Activation of hepatic stellate cells by TGF α and collagen type I is mediated by oxidative stress through c-myb expression.  J Clin Invest . 1995;  96 2461-2468
  PubMedGoogle Scholar
• 98 Bedossa P, Houglum K, Trautwein C. Stimulation of collagen alpha 1 (I) gene expression is associated with lipid peroxidation in hepatocellular injury: a link to tissue fibrosis?.  Hepatology . 1994;  19 1262-1271
  CrossrefPubMedGoogle Scholar
• 99 Kral J G, Schaffner F, Pierson R N, Wang J. Body fat topography as an independent prediction of fatty liver.  Metabolism . 1993;  42 548-551
  CrossrefPubMedGoogle Scholar
• 100 Banerji M A, Buckley M C, Chaiken R L. Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin resistant black men with NIDDM.  Int J Obes Relat Metab Disord . 1995;  19 846-850
  PubMedGoogle Scholar
• 101 Tominaga K, Kurata J H, Chen Y K. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey.  Dig Dis Sci . 1995;  40 2002-2009
  PubMedGoogle Scholar
• 102 Peiris A N, Mueller R A, Smith G A. Splanchnic insulin metabolism in obesity. Influence of body fat distribution.  J Clin Invest . 1986;  78 1648-1657
  PubMedGoogle Scholar
• 103 Meek S E, Nair K S, Jensen M D. Insulin regulation of regional free fatty acid metabolism.  Diabetes . 1999;  48 10-14
  CrossrefPubMedGoogle Scholar
• 104 Barzilai N, Banerjee S, Hawkins M. Calorie restriction reverses hepatic insulin resistance in aging rats by decreasing visceral fat.  J Clin Invest . 1998;  101 1353-1361
  PubMedGoogle Scholar
• 105 Barzilai N, She L, Liu B Q. Surgical removal of visceral fat reverses hepatic insulin resistance.  Diabetes . 1999;  48 94-98
  PubMedGoogle Scholar
• 106 Jick S S, Stender M, Myers M W. Frequency of liver disease in type 2 diabetic patients treated with oral antidiabetic agents.  Diabetes Care . 1999;  22 2067-2071
  PubMedGoogle Scholar
• 107 Casselman W GB, Kaplan A, Bockus H L. Studies of hepatic function in diabetes mellitus, portal cirrhosis and other liver diseases.  Am J Med . 1955;  18 354-384
  CrossrefPubMedGoogle Scholar
• 108 Leevy C M, Ryan C M, Fineberg J C. Diabetes mellitus and liver dysfunction.  Am J Med . 1950;  8 290-299
  CrossrefPubMedGoogle Scholar
• 109 Jaques W E. The incidence of portal cirrhosis and fatty metamorphosis in patients dying with diabetes mellitus.  N Engl J Med . 1953;  249 442-445
  PubMedGoogle Scholar
• 110 Creutzfeldt W, Frerichs H, Sickinger K. Liver diseases and diabetes mellitus.  Prog Liver Dis . 1970;  3 371-407
  PubMedGoogle Scholar
• 111 Abraham S, Furth E E. Receiver operating characteristic analysis of glycogenated nuclei in liver biopsy specimens: quantitative evaluation of their relationship with diabetes and obesity.  Hum Pathol . 1994;  25 1063-1068
  PubMedGoogle Scholar
• 112 Silverman J F, O'Brien K F, Long S. Liver pathology in morbidly obese patients with and without diabetes.  Am J Gastroenterol . 1990;  85 1349-1355
  PubMedGoogle Scholar
• 113 Falchuk K R, Fiske S C, Haggitt R C. Pericentral hepatic fibrosis and intracellular hyalin in diabetes mellitus.  Gastroenterology . 1980;  78 535-541
  PubMedGoogle Scholar
• 114 Younossi Z M, Matteoni C A, Gramlich T L. Diabetes and non-alcoholic fatty liver disease: a worrisome combination.  Gastroenterology . 1999;  116(Abs) 1292
  PubMedGoogle Scholar
• 115 Marceau P, Biron S, Hould F S. Liver pathology and the metabolic syndrome X in severe obesity.  J Clin Endocrinol Metab . 1999;  84 1513-1517
  CrossrefPubMedGoogle Scholar
• 116 Knobler H, Schattner A, Zhornicki T. Fatty liver-an additional and treatable feature of the insulin resistance syndrome.  QJM . 1999;  92 73-79
  CrossrefPubMedGoogle Scholar